Ensysce Biosciences Inc (NQ: ENSC )
0.5001
-0.0454
(-8.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
All News about Ensysce Biosciences Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Ensysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studies
September 14, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Ensysce Presents "A New Generation of Safer Pain Treatments"
September 07, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Ensysce Biosciences Announces IRB Approval of Key Study Protocol
August 08, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/03/tablets-g75adbdd41_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/03/li_auto_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/03/image21.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Ensysce Biosciences Regains Compliance with Nasdaq
June 13, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_9721.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_8829.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://spotlightgrowth.com/wp-content/uploads/2023/05/Ensysce-Biosciences-NASDAQ-ENSC-First-Overdose-Protected-Pain-Medicine-Study-Spotlight-Growth.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/09/pra_group_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/09/aapharma_3.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.